Skip to main content

Market Overview

Mid-Day Market Update: Gold Down Over 2%; Change Healthcare Shares Jump


Midway through trading Wednesday, the Dow traded up 1.63% to 30,886.85 while the NASDAQ rose 0.53% to 12,886.46. The S&P also rose, gaining 1.17% to 3,770.50.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 21,051,000 cases with around 357,380 deaths. India confirmed a total of at least 10,374,930 confirmed cases and 150,110 deaths, while Brazil reported over 7,810,400 COVID-19 cases with 197,730 deaths. In total, there were at least 86,510,930 cases of COVID-19 worldwide with over 1,870,850 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Financial shares gained by 4.6% on Wednesday. Meanwhile, top gainers in the sector included HomeStreet, Inc. (NASDAQ: HMST), up 12%, and Hanmi Financial Corporation (NASDAQ: HAFC), up 14%.

In trading on Wednesday, real estate shares fell 0.4%.

Top Headline

RPM International Inc. (NYSE: RPM) reported better-than-expected earnings for its second quarter.

RPM International posted quarterly adjusted earnings of $1.06 per share, exceeding analysts’ estimates of $1.00 per share. The company posted quarterly sales of $1.49 billion, versus expectations of $1.45 billion.


Equities Trading UP

TAT Technologies Ltd. (NASDAQ: TATT) shares shot up 49% to $7.60 after the company’s fully owned subsidiary, TAT Piedmont Aviation, signed a new strategic contract with Honeywell.

Shares of Isoray, Inc. (NYSE: ISR) got a boost, shooting 171% to $1.4399 after the company disclosed that it received FDA 510(k) clearance for the use of C4 Imaging's Sirius positive-signal MRI Markers with Isoray's Cesium-131, brachytherapy seeds.

Change Healthcare Inc. (NASDAQ: CHNG) shares were also up, gaining 31% to $23.90 after the company announced it will be acquired by United Health's OptumInsight for $25.75 per share in cash.

Equities Trading DOWN

IMARA Inc. (NASDAQ: IMRA) shares tumbled 36% to $15.29 after the company reported Phase 2a clinical trial results of IMR-687 in adult patients with sickle cell disease.

Shares of My Size, Inc. (NASDAQ: MYSZ) were down 20% to $1.36 after the company priced its $1.75 million underwritten public offering of common stock.

Second Sight Medical Products, Inc. (NASDAQ: EYES) was down, falling 23% to $1.7150. Pixium Vision and Second Sight Medical Products reported an agreement to merge in an all-stock transaction.


In commodity news, oil traded up 1.6% to $50.72, while gold traded down 2.4% to $1,907.10.

Silver traded down 2.4% Wednesday to $26.975 while copper rose 0.2% to $3.6450.

Euro zone

European shares were higher today. The eurozone’s STOXX 600 gained 1.36%, the Spanish Ibex Index rose 3.2% and the German DAX 30 gained 1.76%. Meanwhile, the French CAC 40 gained 1.19%, London’s FTSE 100 climbed 3.47% and Italy’s FTSE MIB climbed 2.4%.

Eurozone composite PMI increased to 49.1 in December from November's reading of 45.3. German December composite PMI rose to 52, while services PMI increased to 47. French consumer price index rose 0.2% month-over-month, while Spanish services PMI climbed to 48.


Private payrolls declined by 123,000 in December, versus a 307,000 gain in November, the ADP reported.

The IHS Markit services PMI declined to 54.8 in December versus November's reading of 58.4.

US factory orders rose 1% for November.

US crude oil inventories declined 8 million barrels last week, the Energy Information Administration said.

The Federal Open Market Committee will issue minutes of its latest meeting at 2:00 p.m. ET.


Related Articles (CHNG + EYES)

View Comments and Join the Discussion!

Posted-In: Earnings News Penny Stocks Eurozone Commodities Small Cap Global Intraday Update

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at